We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Robot Assisted Prostate Cancer Surgery Shows Good Results

By HospiMedica International staff writers
Posted on 10 May 2012
A new study shows that robot-assisted surgery for the removal of cancerous prostate has outcomes as good, if not better, than open or laparoscopic radical prostatectomy (RP) techniques.

Researchers at New York-Presbyterian Hospital/Weill Cornell Medical Center (NYP; New York, NY, USA) and Karolinska University Hospital (Stockholm, Sweden) conducted a literature review and meta-analysis to compare margin and perioperative complication rates for open retropubic RP (ORP), laparoscopic RP (LRP), and robot-assisted LRP (RALP). More...
The data were abstracted from 400 original research articles published between 2002 and 2010, representing 167,184 ORP, 57,303 LRP, and 62,389 RALP patients (total 286,876). The primary outcomes were positive surgical margin (PSM) rates, as well as total intra- and peri-operative complication rates.

The results showed that the LRP group had higher positive surgical margin rates than the RALP group, but similar rates to the ORP group. LRP and RALP showed significantly lower blood loss and transfusions, and a shorter length of hospital stay than the ORP group. Total perioperative complication rates were higher for ORP and LRP than for RALP. Total intraoperative complication rates were low for all modalities, but lowest for RALP. Rates for readmission, reoperation, nerve, ureteral, and rectal injury, deep vein thrombosis (DVT), pneumonia, hematoma, lymphocele, anastomotic leak, fistula, and wound infection showed significant differences between groups, generally favoring RALP. The study was published early online on February 24, 2012, in European Urology.

“We would love to be able to directly compare the three prostatectomy surgical techniques, but that may not happen. This study is the first to provide an important, and much needed, analysis of the short term benefits and risks between curative surgeries that many men rely on,” said lead author, Ashutosh Tewari, MD, director of the Prostate Cancer Institute at NYP. “Since the robotic technology is expensive, the patient benefits often get intertwined with the societal costs. It is clear, however, that robotic surgery is the most popular surgical modality today.”

Related Links:

New York-Presbyterian Hospital/Weill Cornell Medical Center
Karolinska University Hospital



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Blood Gas Analyzer
i-Check200
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.